Back to results
US 2017/0290892 A1Published application
Polymeric enkephalin prodrugs
AssigneePeg Biosciences, Inc.
InventorChyi LEE
Life of this patent
Estimating the term…
Abstract
The unique polymeric OGF and enkephalin peptide conjugates with large size polymer attached at the C-terminus through hydrolysable linkage enhancing therapeutic properties of OGF and enkephalin peptides.
Claims23
1-17. (canceled)
An enkephalin-polymer conjugate of the formula:
- [Enkephalin-C(O)—X]n-P
- wherein P is polymer, polymer-lipid or polymer derivative attached to the C terminus carboxyl group without spacer between terminal amino acid and polymer;
- wherein X is an atom or a chemical moiety selected from the group consisting of O, S, imidazo, and phosphate;
- wherein C(O)—X is the hydrolysable linkage comprising the functional group selected from carboxylic ester, thioester, acylimidazo, and phosphonic ester;
- wherein n≧1;
- wherein enkephalins attached to polymer is selected from the group consisting of endogenous enkephalins (including OGF (met-enkephalin) and leu-enkephalin), opioid peptides, proenkephalins, endorphins, dynorphins, proenkephalins and synthetic enkephalin analogues.
3 more elements
A peptide-PEG conjugate having the formula:
- [Peptide-C(O)—O]n—PEG
- wherein n≧1 ;
- wherein —C(O)—O is the peptide C-terminus carboxylic ester linkage connected directly to a PEG polymer;
- and
- wherein PEG is selected from the group consisting of mPEG (monomethoxy polyethylene glycol), linear PEG, branched PEG, multiple-arm PEG, PEG-lipid, PEG copolymers, PEG block copolymers, PEG terpolymers, and PEG polymer derivatives capable of forming hydrogels, liposomes or nanoparticles.
2 more elements
A pre-synthesized C-terminal amino acid-PEG ester derivative having the formula:
- Pm-AA-m PEG
- or
- (Pm-AA)q-PEG
- wherein PEG is linear PEG, branched PEG or multiple-arm PEG;
- wherein mPEG is monomethoxy polyethylene glycol and having structure —O—(CH2CH2O)n—CH3;
- wherein n is about 4 to about 1000;
- wherein m is 0 or 1;
- wherein q≧1;
- wherein P-AA comprises a polypeptide;
- and
- wherein AA is the C-terminal amino acid of the peptide, or a desired amino acid, and said AA is selected from the group consisting of glycine, alanine, phenylalanine, leucine, isoleucine, serine, threonine, glutamine, asparagine, aspartic acid, glutamic acid, histidine, cysteine, tyrosine, lysine, arginine, proline, tryptophan, valine and other homo-amino acids.
8 more elements
A method of forming a releasable biologic which is B or B-AA, comprising reacting AA-mPEG or AA-PEG-AA with B having one or more of the following reactive groups:
- N-hydroxysuccinimide ester, p-nitophenyl ester, N-succinimidyl carbonate, p-nitrophenyl carbonate, carboxyl, carbonyl or aldehyde.
Dependencies are inferred from the claim text.